Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the funding notice and the earlier Revision: v3.4.1.
    Difference
    1.0%
    Check dated 2026-02-11T12:34:22.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Notice about a lapse in government funding stating that information may not be up to date and directing users to status sources. Updated the page revision to v3.4.1 and removed the previous v3.4.0 entry.
    Difference
    1.0%
    Check dated 2026-02-04T06:52:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and introduces color-coded highlights (green for additions, red for deletions) in the history view, along with a revision note updated to v3.4.0 and minor wording changes such as capitalization of 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T04:31:44.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:36:37.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' footer link; these updates do not alter study information, eligibility criteria, or record history content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-23T21:56:43.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:32.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.